Cochrane Database of Systematic Reviews 2007
DOI: 10.1002/14651858.cd006681
|View full text |Cite
|
Sign up to set email alerts
|

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower leg immobilization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
60
1
11

Year Published

2010
2010
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(78 citation statements)
references
References 3 publications
6
60
1
11
Order By: Relevance
“…This risk may be modifiable. Existing evidence suggests that pharmacological prophylaxis could reduce overall VTE event rates in these patients, but the proportional reduction of symptomatic events remains unclear . Recent randomized controlled trials (RCTs) have used different pharmacological agents (low molecular weight heparin [LMWH] and fondaparinux), dosing regimens and outcome measures .…”
Section: Introductionmentioning
confidence: 99%
“…This risk may be modifiable. Existing evidence suggests that pharmacological prophylaxis could reduce overall VTE event rates in these patients, but the proportional reduction of symptomatic events remains unclear . Recent randomized controlled trials (RCTs) have used different pharmacological agents (low molecular weight heparin [LMWH] and fondaparinux), dosing regimens and outcome measures .…”
Section: Introductionmentioning
confidence: 99%
“…To add further context, the most recent Cochrane meta‐analysis of randomized controlled trials (RCTs) of LMWH for prevention of VTE in patients with lower leg immobilization reports a mean incidence of VTE of 18% with a range between 4% and 40% in the placebo groups . The higher rates in this systematic review are attributable to the RCTs utilizing radiologic screening for VTE events, rather than a retrospective review of medical records for symptomatic events.…”
Section: Discussionmentioning
confidence: 92%
“…With the exception of one patient, no VTE prophylaxis was prescribed during the period of immobilization. As prophylaxis with medications such as low molecular weight heparin (LMWH) and aspirin reduces the risk of VTE in a number of orthopedic settings , the study investigators recommended that consideration be given to the routine administration of such chemoprophylaxis, stratified by VTE risk. The use of LMWH for this clinical situation is not funded in New Zealand, so a policy was set in place by the Orthopaedic Department that all patients who were managed with lower limb cast immobilization, including but not limited to Achilles tendon injury, would receive a prescription for a 6‐week course of enteric‐coated aspirin, 100 mg daily, for VTE prophylaxis, unless patient risk factors suggested that more aggressive prophylaxis was indicated.…”
Section: Introductionmentioning
confidence: 99%
“…Alçı ile immobilizasyon Testroote ve ark. (2014) [37] DMAH Orta düzey kanıt Zee ve ark. (2017) [38] NICE (2018)…”
Section: Nice (2018)unclassified